Dallah Healthcare Company (4004.SR)
SAR 132.0
(2.01%)
SAR 132.0
(2.01%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.97 Billion SAR | -0.21% |
| 2022 | 1.97 Billion SAR | 4.67% |
| 2021 | 1.88 Billion SAR | 23.51% |
| 2020 | 1.52 Billion SAR | 47.08% |
| 2019 | 1.04 Billion SAR | 46.81% |
| 2018 | 708.39 Million SAR | 25.64% |
| 2017 | 563.83 Million SAR | 17.13% |
| 2016 | 481.37 Million SAR | 22.39% |
| 2015 | 393.29 Million SAR | 100.08% |
| 2014 | 196.56 Million SAR | 62.52% |
| 2013 | 120.94 Million SAR | 2303.98% |
| 2012 | 5.03 Million SAR | -93.8% |
| 2011 | 81.16 Million SAR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.89 Billion SAR | -1.05% |
| 2024 Q1 | 1.91 Billion SAR | -2.71% |
| 2023 Q4 | 1.97 Billion SAR | 4.19% |
| 2023 FY | 1.97 Billion SAR | -0.21% |
| 2023 Q3 | 1.89 Billion SAR | -1.14% |
| 2023 Q1 | 1.94 Billion SAR | -1.82% |
| 2023 Q2 | 1.91 Billion SAR | -1.32% |
| 2022 Q4 | 1.97 Billion SAR | -1.94% |
| 2022 Q1 | 1.84 Billion SAR | -2.15% |
| 2022 Q3 | 2.01 Billion SAR | 10.65% |
| 2022 FY | 1.97 Billion SAR | 4.67% |
| 2022 Q2 | 1.82 Billion SAR | -1.41% |
| 2021 Q3 | 1.53 Billion SAR | 4.17% |
| 2021 Q1 | 1.48 Billion SAR | -2.69% |
| 2021 FY | 1.88 Billion SAR | 23.51% |
| 2021 Q2 | 1.47 Billion SAR | -0.74% |
| 2021 Q4 | 1.88 Billion SAR | 22.76% |
| 2020 Q1 | 1.11 Billion SAR | 7.36% |
| 2020 Q2 | 1.13 Billion SAR | 1.8% |
| 2020 Q3 | 1.15 Billion SAR | 1.35% |
| 2020 FY | 1.52 Billion SAR | 47.08% |
| 2020 Q4 | 1.52 Billion SAR | 32.78% |
| 2019 Q2 | 1.08 Billion SAR | 31.26% |
| 2019 FY | 1.04 Billion SAR | 46.81% |
| 2019 Q4 | 1.04 Billion SAR | 3.39% |
| 2019 Q3 | 1 Billion SAR | -7.05% |
| 2019 Q1 | 824.46 Million SAR | 16.38% |
| 2018 Q1 | 517.26 Million SAR | -8.26% |
| 2018 FY | 708.39 Million SAR | 25.64% |
| 2018 Q4 | 708.39 Million SAR | -2.69% |
| 2018 Q3 | 728.01 Million SAR | 4.14% |
| 2018 Q2 | 699.07 Million SAR | 35.15% |
| 2017 Q3 | 505.08 Million SAR | 5.11% |
| 2017 Q1 | 393.49 Million SAR | -18.26% |
| 2017 Q4 | 563.83 Million SAR | 11.63% |
| 2017 FY | 563.83 Million SAR | 17.13% |
| 2017 Q2 | 480.52 Million SAR | 22.12% |
| 2016 Q3 | 476.96 Million SAR | 5.2% |
| 2016 FY | 481.37 Million SAR | 22.39% |
| 2016 Q2 | 453.37 Million SAR | 9.87% |
| 2016 Q1 | 412.65 Million SAR | 4.92% |
| 2016 Q4 | 481.37 Million SAR | 0.92% |
| 2015 Q3 | 347.03 Million SAR | -7.15% |
| 2015 Q4 | 393.29 Million SAR | 13.33% |
| 2015 FY | 393.29 Million SAR | 100.08% |
| 2015 Q1 | 322.35 Million SAR | 63.99% |
| 2015 Q2 | 373.76 Million SAR | 15.95% |
| 2014 Q2 | 123.65 Million SAR | 56.73% |
| 2014 FY | 196.56 Million SAR | 62.52% |
| 2014 Q1 | 78.89 Million SAR | -34.77% |
| 2014 Q3 | 196.44 Million SAR | 58.86% |
| 2014 Q4 | 196.56 Million SAR | 0.06% |
| 2013 Q1 | 11.12 Million SAR | 121.2% |
| 2013 Q2 | 9 Million SAR | -19.13% |
| 2013 Q3 | 56.64 Million SAR | 529.34% |
| 2013 FY | 120.94 Million SAR | 2303.98% |
| 2013 Q4 | 120.94 Million SAR | 113.54% |
| 2012 FY | 5.03 Million SAR | -93.8% |
| 2012 Q4 | 5.03 Million SAR | -90.65% |
| 2012 Q3 | 53.79 Million SAR | 0.0% |
| 2011 FY | 81.16 Million SAR | 0.0% |
| 2011 Q4 | 81.16 Million SAR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Mouwasat Medical Services Company | 788.47 Million SAR | -150.278% |
| National Medical Care Company | 330.24 Million SAR | -497.548% |
| Al Hammadi Company For Development and Investment | 314.14 Million SAR | -528.172% |
| Middle East Healthcare Company | 2.48 Billion SAR | 20.596% |
| Dr. Sulaiman Al Habib Medical Services Group Company | 5.18 Billion SAR | 61.929% |
| Canadian General Medical Center Complex Company | 7.71 Million SAR | -25463.631% |
| Arabian International Healthcare Holding Company | 510.21 Million SAR | -286.774% |
| Future Care Trading Co. | 2.29 Million SAR | -85933.287% |
| Naba Alsaha Medical Services Company | 48.19 Million SAR | -3994.807% |
| Lana Medical Co. | 10.46 Million SAR | -18755.444% |
| Al-Modawat Specialized Medical Co. | 2.77 Million SAR | -71082.399% |